Status:
RECRUITING
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
Lead Sponsor:
Andrea Goldmann
Collaborating Sponsors:
Spital Männedorf
Spital Limmattal Schlieren
Conditions:
Graves Disease
Amiodarone-Induced Thyrotoxicosis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the potential differences in morbidity of thyroidectomy (removal of the thyroid gland) depending on the preoperative hormonal status. The main qu...
Detailed Description
Background: Thyrotoxicosis is the clinical condition associated with excessive thyroid hormone activity, usually due to inappropriately high levels of circulating thyroid hormones. The clinical prese...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years of age) undergoing surgical treatment for Graves' disease or Amiodarone-induced thyrotoxicosis (AIT) with biochemically confirmed hyperthyroidism or on specific medication for the treatment of Graves' disease or AIT.
- Patients providing signed informed consent.
Exclusion
- Children and minors (\<18 years).
- Pregnant women.
- Patients unable or unwilling to provide informed consent due to language barriers or intellectual limitations.
- Patients undergoing concurrent parathyroidectomy for primary or secondary hyperparathyroidism, lymph node clearance, or redo surgery.
- Surgical procedures performed for other reasons than Graves' disease or AIT
Key Trial Info
Start Date :
July 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
486 Patients enrolled
Trial Details
Trial ID
NCT06963203
Start Date
July 1 2025
End Date
December 1 2027
Last Update
July 2 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
OLV Ziekenhuis
Aalst, Belgium
2
Universite de Lorraine, Cru Nancy
Nancy, France
3
Evgenidion Hospital Athens
Athens, Greece
4
Universitario Virgen de las Nieves
Granada, Spain